Efficacy and Safety of Dose-dense Chemotherapy (ddEC-ddP) for Neoadjuvant Chemotherapy of HER2-negative Breast Cancer
Status: RECRUITING
Study type: INTERVENTIONAL
Conditions: HER2-negative Breast Cancer|Neoadjuvant Chemotherapy
Interventions: DRUG: Epirubicin|DRUG: Cyclophosphamid|DRUG: Docetaxel|DRUG: Paclitaxel
Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University
Collaborators: Women's Hospital School Of Medicine Zhejiang University|Changxing People's Hospital|Zhejiang Provincial People's Hospital|Hangzhou First People's Hospital, School of Medicine, Zhejiang Universiry|Huizhou Municipal Central Hospital